NCT06617845 Optimizing Brain Stimulation Parameters
| NCT ID | NCT06617845 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Epilepsy; Seizure |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2020-10-20 |
| Primary Completion | 2027-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2020-10-20 with a primary completion date of 2027-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A primary purpose of this study is to better understand what stimulation parameters work best for patients. For example, for Deep Brain Stimulation (DBS) of the Anterior Nucleus of the Thalamus (ANT), it is not clear what stimulation frequency leads is most effective. This study will help assess the effectiveness of low frequency or high frequency stimulation.
Eligibility Criteria
Inclusion Criteria: * Patients who are implanted with a brain stimulation device targeting the anterior nucleus of the thalamus per Mayo Clinic standard of care Exclusion Criteria: * Patients for whom clinical follow-up is not expected during the initial 6-8 months following implant
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06617845 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, studying Epilepsy; Seizure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06617845 currently recruiting?
Yes, NCT06617845 is actively recruiting participants. Contact the research team at headlee.amy@mayo.edu for enrollment information.
Where is the NCT06617845 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT06617845 clinical trial?
NCT06617845 is sponsored by Mayo Clinic. The trial plans to enroll 30 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.